COMPANIES COVERED
Qiagen NVDownload FREE Report Sample
Download Free samplePharmacogenomics Technology Theranostics Companion Diagnostics Market contains market size and forecasts of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global, including the following market information:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market was valued at 5330.8 million in 2021 and is projected to reach US$ 8340.3 million by 2028, at a CAGR of 6.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) include Qiagen NV, GE Healthcare, Agilent Technologies, F Hoffman La Roche, Foundation Medicine, Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmBH and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, by Type, 2021 (%)
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, by Application, 2021 (%)
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
